A rationale for the targeted treatment of oligometastases with radiotherapy.
about
Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancerOligometastatic Prostate CancerPhase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastasesStereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial.OXavidin for tissue targeting biotinylated therapeutics.Molecular radiobiology: the state of the artStereotactic Body radiation therapy for liver tumors with or without rotational intensity modulated radiation therapyThe biology and treatment of oligometastatic cancer.Does Radiotherapy Have Curative Potential in Metastatic Patients? The Concept of Local Therapy in Oligometastatic Breast Cancer.Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review.A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastasesOsseous oligometastases from thymic carcinoma: a case report suggesting the effectiveness of palliative-intent radiotherapy treatment.Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: a single-center experience and review of the literatureLocal therapy and survival in breast cancer with distant metastases.Stereotactic body radiotherapy treatment of extracranial metastases.Stereotactic body radiotherapy for metachronous multisite oligo-recurrence: a long-surviving case with sequential oligo-recurrence in four different organs treated using locally radical radiotherapy and a review of the literature.Extracranial oligometastatic renal cell carcinoma: current management and future directions.Stereotactic ablative radiotherapy for oligometastatic disease in liver.Survival outcomes for oligometastasis in resected non-small cell lung cancer.Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected.Stereotactic body radiation therapy for liver tumours using flattening filter free beam: dosimetric and technical considerations.11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer.Post-recurrence survival analysis of stage I non-small-cell lung cancer.Clinical outcomes following image-guided stereotactic body radiation for pulmonary oligometastases.Stereotactic body radiation therapy for liver metastasis - The linac-based Greater Poland Cancer Centre practice.Is there always a need for invasive treatment of limited liver metastases in renal cell cancer or other solid tumors?Can volumetric modulated arc therapy with flattening filter free beams play a role in stereotactic body radiotherapy for liver lesions? A volume-based analysis.Surgical approach in oligometastatic non-small cell lung cancer.Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directionsThermal Ablation of Bone Metastases
P2860
Q27011293-20282C5E-5464-42B1-9A75-08B853C7FD74Q28075182-F117D2AC-0BD7-4076-B16B-9779592CCC75Q28727917-14BE7C3B-22C6-45EA-8BC6-B789BE87D157Q31075401-C74800ED-3F9C-4A80-91FB-8A2BC2D118F7Q33622702-6B4B4502-6B7A-4306-84B4-C4186C581F0AQ34124274-8B0ADF15-9621-4F37-99BA-425E9394116DQ34461833-F2426A34-590B-4528-BC1A-4A9A622914C2Q35832153-6F4985E1-4BB3-45DF-95D6-6F90BD09FE7CQ35976055-F593C7AE-F8E7-437F-A354-A8E3A2EBF49DQ36360066-C0D51984-8DD9-4CC2-9D26-3B4FA011D138Q36388365-7B7352A1-EA5C-477C-B01E-9CFF4BC3C2F8Q36653090-79EC6691-1C8B-4021-B7E4-5B019E1C5110Q37584420-D83304C7-07CB-4314-8787-4E4B122C6509Q37914092-D262BA33-93E9-4C8D-A334-59DA65FDE5E4Q38046079-E857DDAE-4373-4DFA-B592-9F7F6E5081EBQ38059705-CF15D3EE-E2F6-4454-B0DE-0487D869ACFFQ38209605-E0BB0303-FEA6-4ADE-9175-FCFD12709D6DQ39598540-10C48721-8A76-4EE7-BC25-6D7EF4D397D4Q40700961-488C5914-0DB5-4756-BDC3-56380E34D50BQ41067049-BBBC6860-A917-43A0-B3D5-1615EC50E18CQ42608693-2AD08AA4-5707-4302-B374-E61AA4480C0BQ47693880-38E1BF9B-1423-4551-BF8E-534F4D5D885EQ48006952-BD42E458-FB5E-4994-8843-95AB6031809FQ49356303-2ED28B82-936A-4C5C-BF9D-DD56A2DC7114Q50355067-3613BE1B-78B2-4DB1-8A14-9CE00AE13193Q53064304-09095C9D-D1C9-49C7-9442-D6A0521B741AQ53666997-EEE2CDA1-AE2C-4E6F-A612-AE733718624BQ55049029-9D9EDDA1-E443-48E0-BBFF-F6BD66EC241DQ57177641-A791BCDA-9187-4B98-B560-E735E5BFBC8CQ58602326-B474666A-6BD8-4958-ADE1-36C6FE2C17DC
P2860
A rationale for the targeted treatment of oligometastases with radiotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A rationale for the targeted treatment of oligometastases with radiotherapy.
@en
A rationale for the targeted treatment of oligometastases with radiotherapy.
@nl
type
label
A rationale for the targeted treatment of oligometastases with radiotherapy.
@en
A rationale for the targeted treatment of oligometastases with radiotherapy.
@nl
prefLabel
A rationale for the targeted treatment of oligometastases with radiotherapy.
@en
A rationale for the targeted treatment of oligometastases with radiotherapy.
@nl
P2860
P356
P1476
A rationale for the targeted treatment of oligometastases with radiotherapy.
@en
P2093
Dhara M Macdermed
Joseph K Salama
P2860
P304
P356
10.1002/JSO.21102
P577
2008-09-01T00:00:00Z